1. Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence;Wiktorowicz;Globalization and Health,2018
2. U.S. Food and Drug Administration. Frequently Asked Questions about the FDA Drug Approval Process; 2017 [accessed 16 August 2019]. https://www.fda.gov/drugs/special-features/frequently-asked-questions-about-fda-drug-approval-process.
3. European Medicines Agency. The European regulatory system for medicines; 2016 [accessed 16 August 2019]. https://www.ema.europa.eu/en/documents/leaflet/european-regulatory-system-medicines-european-medicines-agency-consistent-approach-medicines_en.pdf.
4. European Medicines Agency. Authorisation procedures – The centralized procedure; [accessed 16 August 2019], https://ec.europa.eu/health/authorisation-procedures-centralised_en.
5. European Medicines Agency. The Centralised Procedure at the EMA; 2015 [accessed 16 August 2019]. https://www.ema.europa.eu/en/documents/presentation/presentation-centralised-procedure-european-medicines-agency_en.pdf.